Pricing Log in Create free account

Intensity Therapeutics Inc. (INTS) vs Tvardi Therapeutics, Inc. (TVRD)

Intensity Therapeutics Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Tvardi Therapeutics, Inc. is the larger, with a market value of $11.5M against $10.1M — 1.1× the size. Across the 10 metrics below, Intensity Therapeutics Inc. leads on 5 and Tvardi Therapeutics, Inc. on 5.

Valuation

Metric INTS TVRD Biotechnology median
P/E n/m n/m 10.26
P/S n/m 1.05 9.18
P/B 0.87 0.95 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.12 n/m 0.65
EV/Sales n/m 6.83 8.98
Earnings yield (164.06%) (328.24%) (34.89%)
Free cash flow yield (111.37%) (353.24%) (24.52%)

Profitability

Metric INTS TVRD Biotechnology median
Gross margin 0.00% 146.85% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.88%) (126.19%) (50.12%)
Return on assets (139.85%) (85.08%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INTS TVRD Biotechnology median
Revenue growth (TTM) — (55.30%) 6.26%
EPS growth (last fiscal year) 70.74% 71.45% 29.88%
Revenue growth, 5-year CAGR — (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INTS TVRD Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.00 1.87 4.89
Net debt to EBITDA 0.99 1.15 1.01

Dividend

Metric INTS TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INTS TVRD Biotechnology median
Market cap 10.12m 11.53m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack